Jan 31, 2023 | Covid-19, News
The Food and Drug Administration (FDA) vaccine advisory group today recommended streamlining COVID-19 vaccine campaigns by offering just the newer bivalent (two-strain) versions of the vaccine for both primary and booster series. The measure, which passed unanimously,... 
Dec 13, 2022 | Covid-19, News
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children down to 6 months of age. “More children now have the opportunity to update...
